Compare SANJIVANI PA with IND. SWIFT - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANJIVANI PA vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANJIVANI PA IND. SWIFT SANJIVANI PA/
IND. SWIFT
 
P/E (TTM) x 8.3 -2.5 - View Chart
P/BV x - - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SANJIVANI PA   IND. SWIFT
EQUITY SHARE DATA
    SANJIVANI PA
Mar-21
IND. SWIFT
Mar-21
SANJIVANI PA/
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs115 227.9%   
Low Rs62 304.3%   
Sales per share (Unadj.) Rs29.565.7 44.9%  
Earnings per share (Unadj.) Rs1.7-5.5 -30.3%  
Cash flow per share (Unadj.) Rs2.70.5 503.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-52.8-128.4 41.1%  
Shares outstanding (eoy) m8.5054.16 15.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.30.1 553.6%   
Avg P/E ratio x5.1-0.6 -819.9%  
P/CF ratio (eoy) x3.26.4 49.4%  
Price / Book Value ratio x-0.20 604.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m72184 39.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21512 4.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2513,561 7.0%  
Other income Rs m3152 1.7%   
Total revenues Rs m2543,713 6.8%   
Gross profit Rs m21402 5.3%  
Depreciation Rs m9327 2.6%   
Interest Rs m1522 0.2%   
Profit before tax Rs m14-295 -4.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m03 -2.2%   
Profit after tax Rs m14-298 -4.8%  
Gross profit margin %8.511.3 75.6%  
Effective tax rate %-0.5-1.1 46.3%   
Net profit margin %5.7-8.4 -67.5%  
BALANCE SHEET DATA
Current assets Rs m922,652 3.5%   
Current liabilities Rs m5767,062 8.2%   
Net working cap to sales %-193.0-123.9 155.8%  
Current ratio x0.20.4 42.4%  
Inventory Days Days36153 23.5%  
Debtors Days Days96,433,7551,107 8,714,675.6%  
Net fixed assets Rs m1014,064 2.5%   
Share capital Rs m85108 78.4%   
"Free" reserves Rs m-534-7,060 7.6%   
Net worth Rs m-449-6,952 6.5%   
Long term debt Rs m536,442 0.8%   
Total assets Rs m1936,716 2.9%  
Interest coverage x12.20.4 2,807.6%   
Debt to equity ratio x-0.1-0.9 12.7%  
Sales to assets ratio x1.30.5 245.6%   
Return on assets %8.03.3 240.7%  
Return on equity %-3.24.3 -73.7%  
Return on capital %-3.9-44.5 8.7%  
Exports to sales %56.074.2 75.5%   
Imports to sales %3.85.0 76.9%   
Exports (fob) Rs m1412,643 5.3%   
Imports (cif) Rs m10176 5.4%   
Fx inflow Rs m1412,682 5.2%   
Fx outflow Rs m10260 3.7%   
Net fx Rs m1312,422 5.4%   
CASH FLOW
From Operations Rs m6772 0.8%  
From Investments Rs m-4-167 2.6%  
From Financial Activity Rs m-2-483 0.5%  
Net Cashflow Rs m-1122 -0.7%  

Share Holding

Indian Promoters % 19.9 24.1 82.3%  
Foreign collaborators % 0.0 31.5 -  
Indian inst/Mut Fund % 16.5 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 80.2 44.5 180.3%  
Shareholders   4,829 12,424 38.9%  
Pledged promoter(s) holding % 0.0 68.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANJIVANI PA With:   DR. REDDYS LAB  OMKAR PHARMACHEM  ISHITA DRUGS  SOLARA ACTIVE PHARMA SCIENCES  NORRIS MEDICINES  



Today's Market

Declining FMCG Sales, Shriram Properties IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note on Friday. Markets reversed their two-day winning streak with losses in index heavyweight Reliance Industries.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANJIVANI PA SHARE PRICE


Dec 3, 2021 (Close)

TRACK SANJIVANI PA

  • Track your investment in SANJIVANI PA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANJIVANI PA - NATCO PHARMA COMPARISON

COMPARE SANJIVANI PA WITH

MARKET STATS